stearoylethanolamide has been researched along with Obesity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gula, NM; Klimashevsky, VM; Kosiakova, GV; Onopchenko, OV; Oz, M | 1 |
| Berdyshev, AG; Hula, NM; Kosiakova, HV; Onopchenko, OV; Panchuk, RR; Stoika, RS | 1 |
2 other study(ies) available for stearoylethanolamide and Obesity
| Article | Year |
|---|---|
N-stearoylethanolamine restores pancreas lipid composition in obesity-induced insulin resistant rats.
Topics: Animals; Diet, High-Fat; Ethanolamines; Insulin; Insulin Resistance; Lipid Metabolism; Lipids; Male; Obesity; Pancreas; Rats; Rats, Sprague-Dawley; Stearic Acids | 2015 |
N-Stearoylethanolamine suppresses the pro-inflammatory cytokines production by inhibition of NF-κB translocation.
Topics: Active Transport, Cell Nucleus; Animals; Anti-Inflammatory Agents; Body Weight; Cell Line, Tumor; Cell Nucleus; Cytokines; Dose-Response Relationship, Drug; Ethanolamines; Insulin; Insulin Resistance; Lipopolysaccharides; Macrophages, Peritoneal; Mice; NF-kappa B; Obesity; Rats; RNA, Messenger; Stearic Acids | 2015 |